91,590 Shares in Oscar Health, Inc. (NYSE:OSCR) Acquired by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. purchased a new stake in Oscar Health, Inc. (NYSE:OSCR) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor purchased 91,590 shares of the company’s stock, valued at approximately $1,943,000.

Several other large investors have also recently modified their holdings of the business. Price T Rowe Associates Inc. MD grew its stake in shares of Oscar Health by 153.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after purchasing an additional 2,409,160 shares during the last quarter. First Light Asset Management LLC raised its position in shares of Oscar Health by 117.3% in the 1st quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock worth $31,265,000 after acquiring an additional 1,134,919 shares in the last quarter. Renaissance Technologies LLC boosted its position in shares of Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after purchasing an additional 934,600 shares in the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of Oscar Health during the 2nd quarter worth approximately $14,716,000. Finally, Bank of New York Mellon Corp increased its stake in shares of Oscar Health by 161.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company’s stock valued at $22,038,000 after acquiring an additional 860,226 shares in the last quarter. Institutional investors own 75.70% of the company’s stock.

Oscar Health Price Performance

OSCR stock opened at $18.09 on Tuesday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91. The business has a 50-day simple moving average of $18.74 and a two-hundred day simple moving average of $18.43. The company has a market capitalization of $4.38 billion, a P/E ratio of -139.15, a price-to-earnings-growth ratio of 33.28 and a beta of 1.67. Oscar Health, Inc. has a 52-week low of $5.65 and a 52-week high of $23.79.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The business had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.13 billion. During the same quarter in the prior year, the company posted ($0.07) earnings per share. Oscar Health’s revenue was up 44.6% compared to the same quarter last year. Research analysts expect that Oscar Health, Inc. will post 0.01 EPS for the current fiscal year.

Insider Transactions at Oscar Health

In other Oscar Health news, CFO Richard Scott Blackley sold 29,957 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $511,066.42. Following the completion of the sale, the chief financial officer now directly owns 853,875 shares of the company’s stock, valued at approximately $14,567,107.50. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the completion of the transaction, the executive vice president now owns 392,607 shares in the company, valued at approximately $6,697,875.42. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Richard Scott Blackley sold 29,957 shares of Oscar Health stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $17.06, for a total transaction of $511,066.42. Following the completion of the sale, the chief financial officer now directly owns 853,875 shares in the company, valued at approximately $14,567,107.50. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 169,569 shares of company stock worth $3,007,069 in the last quarter. 25.11% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms have commented on OSCR. UBS Group assumed coverage on shares of Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target for the company. Piper Sandler restated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $24.00.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.